Matthew Meyerson
- Cancer Research top 0.01%
- Cancer Genomics and Diagnostics 68
- Oncology top 0.01%
- HER2/EGFR in Cancer Research 25
- Pulmonary and Respiratory Medicine top 0.01%
- Lung Cancer Treatments and Mutations 64
- Molecular Biology top 0.02%
- RNA modifications and cancer 40
- Epigenetics and DNA Methylation 23
- Genomics and Chromatin Dynamics 17
- Genomics and Phylogenetic Studies 15
- Pathology and Forensic Medicine top 0.1%
-
- Genomic variations and chromosomal abnormalities 17
- Co-authors
- Gad GetzMichael J. EckPasi A. JänneHeidi GreulichBruce E. JohnsonStacey GabrielTitus J. BoggonWilliam R. Sellers
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Matthew Meyerson
277 papers receiving 57.8k citations
Hit Papers
Peers
Comparison fields: 5 of 194
- Cancer Research 13.8k
- Oncology 22.7k
- Pulmonary and Respiratory Medicine 19.9k
- Molecular Biology 34.3k
- Pathology and Forensic Medicine 4.2k
Countries citing papers authored by Matthew Meyerson
This map shows the geographic impact of Matthew Meyerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Meyerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Meyerson more than expected).
Fields of papers citing papers by Matthew Meyerson
This network shows the impact of papers produced by Matthew Meyerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Meyerson. The network helps show where Matthew Meyerson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthew Meyerson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 26 | |
| 2 | 2020 | 58 | |
| 3 | 2018 | 43 | |
| 4 | 2017 | 85 | |
| 5 | 2017 | 49 | |
| 6 | 2015 | 19 | |
| 7 | 2014 | 229 | |
| 8 | 2014 | 30 | |
| 9 | 2013 | 90 | |
| 10 | 2012 | 131 | |
| 11 | Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profilingbreakdown → | 2011 | 732 |
| 12 | 2011 | 384 | |
| 13 | 2011 | 110 | |
| 14 | Recurrent BRAF mutations in Langerhans cell histiocytosisbreakdown → | 2010 | 742 |
| 15 | The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATPbreakdown → | 2008 | 1564 |
| 16 | 2006 | 98 | |
| 17 | 2006 | 206 | |
| 18 | 2006 | 388 | |
| 19 | 2005 | 242 | |
| 20 | EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapybreakdown → | 2004 | 7539 |
About Matthew Meyerson
Matthew Meyerson is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 287 papers that have together received 58.9k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (68 papers), Lung Cancer Treatments and Mutations (64 papers), RNA modifications and cancer (40 papers), HER2/EGFR in Cancer Research (25 papers), Epigenetics and DNA Methylation (23 papers), Genomics and Chromatin Dynamics (17 papers), Genomic variations and chromosomal abnormalities (17 papers) and Genomics and Phylogenetic Studies (15 papers). The work is most often cited by research in Cancer Research (13.8k citations), Oncology (22.7k citations) and Pulmonary and Respiratory Medicine (19.9k citations). Matthew Meyerson has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Gad Getz, Michael J. Eck, Pasi A. Jänne, Heidi Greulich, Bruce E. Johnson, Stacey Gabriel, Titus J. Boggon, William R. Sellers, Rameen Beroukhim and Craig H. Mermel. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.